Cite

    Mulley, W. et al. (2017). Long‐term graft survival in patients with chronic antibody‐mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab. Clinical transplantation. 31 (9), p. n/a. [Online].